Clinically meaningful risk factors for recurrence in T1 colorectal cancer treated with endoscopic resection alone identified by unsupervised machine learning: a multicenter study
BACKGROUND AND STUDY AIM: Identifying high-risk patients for recurrence after endoscopic resection (ER) of T1 colorectal cancer (CRC) remains challenging. This study aimed to identify recurrence-risk subtypes and develop an interpretable risk stratification framework. PATIENTS AND METHODS: This retrospective study analyzed 1123 patients with T1 CRC treated with ER alone across 27 Japanese institutions (July 2009-December 2016). Patients were divided into development (68%) and evaluation (32%) cohorts based on institutional stratification. K-means clustering was applied to clinicopathological variables to identify recurrence-risk subtypes. A decision tree classifier was subsequently developed to generate transparent risk stratification rules. RESULTS: Three distinct subtypes were identified in the development cohort. Subtype 1 exhibited a numerically higher recurrence rate (5.4%) than subtype 2 (0.9%) and subtype 3 (1.4%). Although subtypes 2 and 3 showed comparable recurrence rates, they were clearly differentiated by morphology (flat vs. polypoid). In the evaluation cohort, subtype 1 continued to show a numerically higher recurrence (4.8%) compared with subtypes 2 (1.6%) and 3 (1.1%). The decision tree model stratified recurrence risk hierarchically: submucosal invasion <1,000μm indicated low risk, whereas invasion ≥1,000μm required morphological assessment, with polypoid lesions classified as high risk and flat lesions further stratified using a 2,000μm threshold. CONCLUSIONS: Three clinically distinct recurrence risk subtypes were identified in T1 CRC following ER, suggesting that morphological subclassification of T1b lesions may refine stratification beyond conventional depth-based criteria. The decision framework offers a preliminary exploratory basis for recurrence risk assessment in this population.
Authors
- Soichiro Ishihara (ORCID: https://orcid.org/0000-0003-0543-0045)
- Masayoshi Yamada (ORCID: https://orcid.org/0000-0003-3979-5560)
- Kazuhiro Sakamoto (ORCID: https://orcid.org/0000-0002-7087-1667)
- Manabu Takamatsu (ORCID: https://orcid.org/0000-0001-9601-5802)
- Shinobu Ohnuma (ORCID: https://orcid.org/0000-0002-0205-8957)
- Kazutomo Togashi (ORCID: https://orcid.org/0000-0002-4080-5335)
- Kinichi Hotta (ORCID: https://orcid.org/0000-0001-5608-0968)
- Shinji Tanaka (ORCID: https://orcid.org/0000-0002-0480-3957)
- Xin Zhu (ORCID: https://orcid.org/0000-0002-4376-0806)
- Yusuke Saitoh
- Shinpei Minami
- Xue Zhou
- H Ikematsu
- K Hashimoto
- H Ueno
- Y Tamaru
- S Nagata
- Megumi Ishiguro
- Kenichi Sugihara
- Koji Komori
- Yoshiki Kajiwara
- Kenji Matsuda
- Shiro Oka
- Takashi Okuyama
- Kazutaka Yamada
Institutions
- Kurume University (JP)
- Fukushima Medical University (JP)
- University of Aizu (JP)
- Wakayama Medical University (JP)
- Tohoku University (JP)
- Shizuoka Cancer Center (JP)
- Hiroshima City Asa Citizens Hospital (JP)
- Asahikawa City Hospital (JP)
- Hiroshima University Hospital (JP)
- Tochigi Cancer Center (JP)
- Takano Hospital (JP)
- Aichi Cancer Center (JP)
- The Cancer Institute Hospital (JP)
- National Cancer Center Hospital East (JP)
- Juntendo University Hospital (JP)
- Tokyo National Hospital (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Kure Medical Center (JP)
- Onomichi General Hospital (JP)
- Institute of Science Tokyo (JP)
- National Defense Medical College (JP)
- The University of Tokyo (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Endoscopy
- Published
- 2026-07-18
- DOI
- https://doi.org/10.1055/a-2917-8805
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00